Benzinga | Sep 25, 2020 11:49AM EDT

Canaccord Genuity Maintains Buy on Exact Sciences, Raises Price Target to $120

Canaccord Genuity analyst Max Masucci maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $115 to $120.